Suchergebnisse - "Gatell, Jose"

PubPharm (576)

1

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von de Lazzari, E. | Negredo, E. | Domingo, P. | +12

2

Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir : A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Sempere, A. | Assoumou, L. | González-Cordón, A. | +28

3

The HIV-1 ribonucleoprotein dynamically regulates its condensate behavior and drives acceleration of protease activity through membraneless granular phase separation

enthalten in: bioRxiv.org | 2023

von Lyonnais, S. | Sadiq, S. | Lorca-Oró, C. | +15

4

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von González-Cordón, A. | Assoumou, L. | Moyle, G. | +117

5

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis

enthalten in: AIDS research and human retroviruses | 2023

von Leal, L. | Guardo, A. | Bedoya, L. | +10

6

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk : A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waters, L. | Assoumou, L. | González-Cordón, A. | +121

7

Immunological and virological findings in a patient with exceptional post-treatment control : a case report

enthalten in: The lancet. HIV | 2023

von Climent, N. | Ambrosioni, J. | González, T. | +59

CommentIn: Lancet HIV. 2023 Jan;10(1):e5-e7. - PMID 36354048

8

Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir : a substudy of the NEAT022 study

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Saumoy, M. | Sánchez-Quesada, J. | Assoumou, L. | +12

9

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4+ T Cells From HIV-1 Patients

enthalten in: Frontiers in virology (Lausanne, Switzerland) | 2022

von Xufré, C. | González, T. | Leal, L. | +7

10

The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation

enthalten in: Viruses | 2021

von Lyonnais, S. | Sadiq, S. | Lorca-Oró, C. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[58]